Welcome to the Novo Nordisk Inc. (NNI) Investigator-Sponsored Studies (ISS) Management system. This site allows you to submit an application to NNI for ISS support. The site is restricted to the submission of ISS grant requests only. 

The requirements for submission of an ISS application includes but is not limited to a detailed full protocol and line-item budget (when applicable). Submission of an application does not constitute an agreement by NNI to support your ISS study. The final decision to support an ISS is made only after comprehensive review of your application has occurred by the Novo Nordisk teams on both the US (NNI) and Global level. For more information about our ISS program please refer to the resources below.

NNI ISS Website: Investigator Sponsored Studies Program | Novo Nordisk U.S. (novonordisk-us.com) 

NNI ISS Program Overview: NNI Quick Reference Guide

NNI ISS Portal Navigation & Application Submission: NNI ISS Portal Reference Guide

 *Please note that no  new ISS applications requesting semaglutide (e.g., injectables and oral formulation) are being accepted at the moment and the ISS process for semaglutide will remain on hold until further notice.

Should you have questions about the NNI ISS program, please reach out to your local Field Medical Liaison or email theprogram at NNI_ISS@novonordisk.com.

If you need technical assistance, please call + 1 718-576-1406 or click here to contact the SteepRock system administrator.

If you would like to submit a grant request for an independent medical education program, please visit  https://www.novonordisk.com/external-support